Psoriatic arthritis or overlap syndrome.
In this work we describe a case of papillophlebitis type II according to Hayreh in a young woman affected by psoriatic arthritis. On the basis of an analysis of the patient's HLA system--B7, DR7 (characteristics of psoriatic arthritis) and B51 (present in 81% of patients affected by Behçet's syndrome)--we hypothesize that this may be a case of an 'overlap syndrome'. In rheumatology, this term usually refers to the presence in a single patient of characteristic features of two or more diseases. In fact, papillophlebitis is a complication which has never been described in psoriatic arthritis, while, in Behçet's syndrome, retinal vasculitis is well known.
Rechichi
C F
CF
Institute of Ophthalmology, University of Messina, Italy.
Trombetta
C
C
Scullica
M G
MG
Tripodi
G
G
Quattrocchi
E
E
Ferreri
G
G
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D005260:Female; D006046:Gold / Q000627:therapeutic use; D015793:HLA-B7 Antigen / Q000032:analysis; D015809:HLA-DR7 Antigen / Q000032:analysis; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D012171:Retinal Vessels; D013577:Syndrome; D014657:Vasculitis / Q000150:complications* / Q000188:drug therapy / Q000276:immunology
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D015793:HLA-B7 Antigen; D015809:HLA-DR7 Antigen; D006046:Gold; D011239:Prednisolone; D007213:Indomethacin